MétaCan
Menu
Back to cohort
Record W4414439812 · doi:10.1016/j.ajpc.2025.101192

GALECTIN-3 AND LONG-TERM CARDIOVASCULAR RISK IN PATIENTS WITH MYOCARDIAL INFARCTION TREATED WITH PCI: A META-ANALYSIS OF 5,457 PATIENTS

2025· article· en· W4414439812 on OpenAlexaboutno aff
R. Moreno, Kathereen Oliden, C. Guzmán

Bibliographic record

VenueAmerican Journal of Preventive Cardiology · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicGalectins and Cancer Biology
Canadian institutionsnot available
Fundersnot available
KeywordsMaceMyocardial infarctionHazard ratioProspective cohort studyProportional hazards modelBiomarkerPercutaneous coronary interventionCohort study

Abstract

fetched live from OpenAlex

Novel Biomarkers Residual cardiovascular risk remains a challenge after successful percutaneous coronary intervention in patients with myocardial infarction (MI). Galectin-3, a biomarker of inflammation and fibrosis, has been proposed as a prognostic tool, but its predictive value for long-term cardiovascular events post-PCI is not well defined. We conducted a systematic review and meta-analysis to evaluate the association between Galectin-3 levels and major adverse cardiovascular events (MACE) in this population. We conducted a systematic review and meta-analysis following PRISMA guidelines. Pubmed, Embase, Web of Science, and CENTRAL were searched for prospective cohort studies reporting hazard ratios (HRs) for MACE in relation to Galectin-3 levels measured at baseline in post-PCI patients with MI. Only studies reporting multivariable-adjusted HRs were included. A random-effects model was used to calculate the pooled HR. Risk of bias was assessed using the Newcastle-Ottawa Scale. A total of five prospective cohort studies were included, involving 5,457 patients with myocardial infarction treated with PCI. In all studies, Galectin-3 was measured in close proximity to the index PCI, typically during hospitalization, and patients were stratified according to biomarker concentration (high vs. low). The primary outcome was major adverse cardiovascular events (MACE), consistently defined across studies as a composite of all-cause mortality, nonfatal myocardial infarction, stroke, and repeat revascularization. The pooled adjusted hazard ratio for elevated Galectin-3 levels was 1.75 (95% CI: 1.37–2.23; p < 0.00001), indicating a 75% increased relative risk of long-term MACE in patients with higher Galectin-3 levels. All included studies reported hazard ratios derived from multivariable Cox regression models, adjusted for major clinical covariates including age, sex, diabetes, hypertension, renal function, and left ventricular ejection fraction. Elevated Galectin-3 levels identify post-MI patients at increased risk of long-term adverse cardiovascular events, regardless of revascularization success. This biomarker may uncover residual biological risk not captured by conventional imaging or clinical scores. These findings support its integration into risk assessment models and suggest a potential role for Galectin-3 in advancing precision-based preventive strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.008
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.013
Threshold uncertainty score0.043

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0080.013
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0130.046
Bibliometrics0.0030.005
Science and technology studies0.0010.000
Scholarly communication0.0030.001
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.222
Teacher spread0.216 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAmerican Journal of Preventive CardiologySame topicGalectins and Cancer BiologyFrench-language works237,207